NCT00473070CompletedPhase 3
A Clinical Study of Tobradex AF
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Alcon Research
- Enrollment
- 900
- Locations
- 2
- Primary Endpoint
- Concentration of dexamethasone in aqueous humor following a single topical ocular administration
Study Overview
Brief Summary
The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adult patients requiring cataract surgery
Exclusion Criteria
- •Age related
Outcomes
Primary Outcomes
Concentration of dexamethasone in aqueous humor following a single topical ocular administration
Time Frame: Periodic
Secondary Outcomes
- Changes in external and internal ocular structures, intraocular pressure, vision and other side effects(Periodic)
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Phase 3
A Bioequivalence Study of Tobradex AFCataractNCT00362895Alcon Research995
Completed
Phase 1
A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male ParticipantsHealthyNCT06342596Eli Lilly and Company16
Recruiting
Phase 1
A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)HealthyType 1 Diabetes MellitusNCT06280703Eli Lilly and Company118
Completed
Phase 4
Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and CyclophosphamideBreast CancerBreast Cancer FemaleNCT02502864H. Lee Moffitt Cancer Center and Research Institute9
Completed
Phase 1
A Study to Compare Two Tablet Forms of Tafamidis in Healthy ParticipantsHealthyNCT05482308Pfizer12